"Pyridines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
Descriptor ID |
D011725
|
MeSH Number(s) |
D03.383.725
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Pyridines".
Below are MeSH descriptors whose meaning is more specific than "Pyridines".
This graph shows the total number of publications written about "Pyridines" by people in this website by year, and whether "Pyridines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 3 | 0 | 3 |
1997 | 1 | 1 | 2 |
1998 | 1 | 1 | 2 |
1999 | 0 | 2 | 2 |
2000 | 0 | 2 | 2 |
2001 | 1 | 1 | 2 |
2002 | 0 | 5 | 5 |
2003 | 0 | 5 | 5 |
2004 | 1 | 3 | 4 |
2005 | 4 | 5 | 9 |
2006 | 2 | 5 | 7 |
2007 | 7 | 4 | 11 |
2008 | 8 | 4 | 12 |
2009 | 8 | 8 | 16 |
2010 | 9 | 3 | 12 |
2011 | 4 | 10 | 14 |
2012 | 5 | 7 | 12 |
2013 | 9 | 4 | 13 |
2014 | 7 | 2 | 9 |
2015 | 8 | 3 | 11 |
2016 | 10 | 2 | 12 |
2017 | 9 | 3 | 12 |
2018 | 8 | 4 | 12 |
2019 | 4 | 5 | 9 |
2020 | 1 | 2 | 3 |
2021 | 4 | 3 | 7 |
2022 | 0 | 1 | 1 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pyridines" by people in Profiles.
-
Inhibition of the MNK1/2-eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer. Mol Cancer Ther. 2023 02 01; 22(2):192-204.
-
Focused update: Guidelines of care for the management of actinic keratosis. J Am Acad Dermatol. 2022 08; 87(2):373-374.e5.
-
A bivalent cyclic RGD-siRNA conjugate enhances the antitumor effect of apatinib via co-inhibiting VEGFR2 in non-small cell lung cancer xenografts. Drug Deliv. 2021 Dec; 28(1):1432-1442.
-
Inhibition of Sphingosine-1-Phosphate Receptor 2 by JTE013 Promoted Osteogenesis by Increasing Vesicle Trafficking, Wnt/Ca2+, and BMP/Smad Signaling. Int J Mol Sci. 2021 Nov 08; 22(21).
-
A phase 1b/2a study of soticlestat as adjunctive therapy in participants with developmental and/or epileptic encephalopathies. Epilepsy Res. 2021 08; 174:106646.
-
Lemborexant (Dayvigo) for the Treatment of Insomnia. Am Fam Physician. 2021 02 15; 103(4):241-242.
-
Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis. N Engl J Med. 2021 02 11; 384(6):512-520.
-
Effect of zinc pyrithione shampoo treatment on skin commensal Malassezia. Med Mycol. 2021 Feb 04; 59(2):210-213.
-
Elexacafator/tezacaftor/ivacaftor resolves subfertility in females with CF: A two center case series. J Cyst Fibros. 2021 05; 20(3):399-401.
-
Inhibition of RAS: proven and potential vulnerabilities. Biochem Soc Trans. 2020 10 30; 48(5):1831-1841.